Gender Differences in the Role of Serum Uric Acid for Predicting Cardiovascular Events in Patients with Coronary Artery Disease
|
|
- Morgan Hubbard
- 5 years ago
- Views:
Transcription
1 Original ORIGINAL Article ARTICLE Korean Circulation J 007;37: ISSN c 007, The Korean Society of Circulation Gender Differences in the Role of Serum Uric Acid for Predicting Cardiovascular Events in Patients with Coronary Artery Disease Dae-Woo Hyun, MD, Ki-Hong Kim, MD, Hyun-Ju Yoon, MD, Taek-Geun Kwon, MD, Ki-Young Kim, MD and Jang-Ho Bae, MD Department of Cardiology, Heart Center, Konyang University Hospital, Daejeon, Korea ABSTRACT Background and Objectives:Serum uric acid has been reported to be an independent risk factor for coronary artery disease (CAD) and a predictor of mortality in patients with CAD. Yet there is gender difference for the serum uric acid levels. We evaluated the influence of the uric acid levels on major adverse cardiovascular events (MACEs) in patients with CAD according to their gender. Subjects and Methods:Of the 777 patients with angiographically proven CAD, 660 patients (378 males, 57.3%) were followed up a median of 18 month (maximum: 61 month). The MACEs included acute myocardial infarction, cerebral infarction, coronary artery bypass graft, percutaneous coronary intervention due to de novo lesion during follow up, new onset congestive heart failure and sudden cardiac death. Results:MACEs in men were associated with acute coronary syndrome (ACS)(odds ratio (OR):.03, 95% confidence intervals (CI): 1.01 to 3.96, p=0.038), multi-vessel disease (OR: 3.68, 95% CI: 1.8 to 7.47, p=0.000) and the serum uric acid levels (OR: 1.3, 95% CI: 1.01 to 1.50, p=0.044), according to multivariate Cox regression analysis. For women, MACEs were associated with multi-vessel disease (OR:.43, 95% CI: 1.15 to 5.13, p=0.00) and the highest uric acid quartile (OR:.64, 95% CI: 1.31 to 5.30, p=0.006) according to multivariate Cox regression analysis. For all patients, the highest uric acid quartile was associated with an increased risk of MACE (p=0.000), and CHF was the major contributor to the observed MACEs (p=0.004). Conclusion:In male patients with CAD, the serum uric acid level is a predictor of cardiovascular events, and the highest uric acid quartile is a predictor of cardiovascular events in women. (Korean Circulation J 007;37:196-01) KEY WORDS:Uric acid;gender;coronary artery disease. Introduction Elevated serum uric acid(sua), as an end product of purine metabolism, reflects increased xanthine oxidase activity, and this has been shown to be related with endothelial dysfunction, cardiovascular disease and insulin resistance. 1-4) It has recently been reported that SUA is an independent predictor of mortality for patients with coronary artery disease(cad), including acute myocardial infarction(ami) or congestive heart failure(chf), although it does not have a causal role in the development of CAD, death from cardiovascular Received:January 30, 007 Revision Received:February 8, 007 Accepted:March 6, 007 Correspondence:Jang-Ho Bae, MD, Department of Cardiology, Heart Center, Konyang University Hospital, 685 Gasoowon-dong, Seo-gu, Daejeon , Korea Tel: , Fax: jhbae@kyuh.co.kr disease or death from all causes, according to the Framingham heart study. 5-8) However, there is a gender difference in the SUA levels and also in the relation between SUA and cardiovascular disease. 9)10) We performed this study to evaluate the role of the gender differences of the SUA levels on major adverse cardiovascular events(mace) such as death, myocardial infarction, stroke, CHF, percutaneous coronary intervention(pci) and coronary artery bypass graft(cabg) surgery in 660 consecutive patients who suffered with CAD. Subjects and Methods Study design and the patient population All the patients who underwent coronary angiography at Konyang University Hospital were enrolled in a registry that included the baseline demographic, clinical and angiographic characteristics. These patients visited 196
2 Dae-Woo Hyun, et al: Uric Acid and the Prognosis for Female Patients with Coronary Artery Disease 197 hospital once or twice per two months or they were contacted at 6 and 1 months after the procedure and yearly thereafter. The data base was searched for all the patients who had at least 30% luminal stenosis according to coronary angiography and who also had their laboratory data available, including the serum uric acid level within two weeks of angiography; all the patients were treated between June 000 and June 001 at Konyang University Hospital in Daejeon, Korea. These dates were chosen because our practice remained relatively stable with regards to adjunctive medical therapies(in particular clopidogrel) and stent types(bare metal) if they underwent PCI. For patients who underwent two procedures during the study period, only the first procedure was included. The baseline data on the patients was available from the database, including the patients clinical characteristics and medication use. Clinical follow-up Follow up was achieved mainly through the database and a chart review(574, 87.0%), and with telephone calls(86, 13.0%) at 6 months and then yearly after the procedure. The measured outcomes were sudden cardiac death, AMI(defined by an increase in the cardiac biomarkers), CHF(defined by the Framingham criteria for the diagnosis of CHF), PCI or CABG for de novo lesion, and stroke. Statistical analysis The data was analyzed separately for the women and men. Continuous variables are summarized as means ±SDs. Discrete variables are presented as group percentages. Kaplan-Meier estimates were used to describe the survival rates. For the time-to-event analysis, followup began at the date of discharge. One-way analysis of variance, Pearson s chi-squared test and the log-rank test were used to test the significance of group differences. Cox regression analysis was used to estimate the hazard ratios for the SUA levels and the other clinical variables. Results Patient characteristics Of the 777 patients with angiographically proven CAD, 660 patients(378 males, 57.3%) were followed up for a median of 18 months(maximum: 61 months). 117 patients of the 777 patients were excluded due to loss to follow up, and they had unknown clinical outcomes. The patients SUA levels were measured within two weeks of their procedures during the study period. The study patients were divided into four groups according to the quartiles of the serum uric acid levels. For the men, the lowest quartile was SUA(4.30 mg/ dl(n=94, 4.9%), the second quartile was 4.30 mg/ dl<sua(5.17 mg/dl(n=96, 5.4%), the third quartile was 5.17 mg/dl<sua(6.13 mg/dl(n=94, 4.9%), and the highest quartile was SUA>6.13 mg/dl(n=94, 4.9%). For the women, the lowest quartile was SUA (3.51 mg/ dl(n=70, 4.8%), the second quartile was 3.51 mg/ dl<sua(4.33 mg/dl(n=73, 5.9%), the third quartile was 4.33 mg/dl<sua(5.11 mg/dl(n=69, 4.5%), and the highest quartile was SUA>5.11 mg/dl(n=70, 4.8%)(Fig. 1). The median follow up was 7 months (maximum: 6 months). Compared with the women, the men were younger, had a lower body mass index, a greater incidence of acute coronary syndrome, they smoked more, had less hypertensive patients, lower total cholesterol, lower highdensity and low-density lipoprotein cholesterol and higher serum creatinine and SUA. Before the eighth decade, the SUA level was significantly higher in the men than in the women, but the SUA was not significantly different between the genders at the eight and ninth decade(table 1). Clinical outcomes At the end of the follow up period, there were 37 (9.8%) male patients with MACEs, whereas there were 3 female patients(11.3%) patients with MACEs(Table ). According to the MACE-free survival curves by the SUA quartiles, there was no significant divergence among the quartiles for men. For the women, the highest uric acid quartile group showed a significant divergence from the other three quartiles(fig. ). According to the univariate analysis, the incidence of MACEs for the men was associated with ACS, multivessel disease and the SUA level, whereas that of the women was associated with ACS, multi-vessel disease and the highest uric acid quartile(table 3). Those clinical and laboratory variables predicting the univariate risk with a p 0.05 were entered into multivariate Cox regression analysis. Multivariate analysis revealed that Serum uric acid (mg/dl) Men Women Quartile Quartile 3 Quartile 4 Quartiles of Serum Uric Acid Fig. 1. Levels of uric acid according to the quartiles of serum uric acid for the men and women.
3 198 Korean Circulation J 007;37: Table 1. Clinical characteristics of men and women Variables All patients (n=660) Men (n=378) Women (n=8) p Age (years) 59.± ± ± BMI (kg/m ) 4.4±3. 4.8± ± ACS (%) Multi-vessel disease (%) Risk factors Smoking (%) Hypertension (%) Diabetes (%) Dyslipidemia (%) Blood test Total cholesterol (mg/dl) 186.6± ± ± Triglycerides (mg/dl) 187.0± ± ± HDL cholesterol (mg/dl) 41.± ± ± LDL cholesterol (mg/dl) 109.± ± ± Creatinine (mg/dl) 1.0± ± ± Uric acid (mg/dl) Fifth decade 4.9± ± ± Sixth decade 5.0± ±1.5 4.± Seventh decade 4.9± ± ± Eighth decade 4.8± ± ± Ninth decade 4.9± ± ± BMI: body mass index, ACS: acute coronary syndrome, HDL: high density lipoprotein, LDL: low density lipoprotein 1.0 Event-Free cumulative survival A p of Log Rank statistics Quartile Quartile 3 Quartile 4 B p of Log Rank statistics Quartile Quartile 3 Quartile 4 C p of Log Rank statistics Quartile 3 Quartile Quartile Time (months) Time (months) Time (months) Fig.. Kaplan-Meier curve for event-free cumulative survival according to the quartiles of serum uric acid (A: for all patients. B: for men. C: for women). In men, the lowest quartile is SUA 4.30 mg/dl (n=94, 4.9%), the second quartile is 4.30 mg/dl<sua 5.17 mg/dl (n=96, 5.4%), the third quartile is 5.17 mg/dl <SUA 6.13 mg/dl (n=94, 4.9%), and the highest quartile is SUA>6.13 mg/dl (n=94, 4.9%), respectively. In women, the lowest quartile is SUA 3.51 mg/dl (n=70, 4.8%), the second quartile is 3.51 mg/dl<sua 4.33 mg/dl (n=73, 5.9%), the third quartile is 4.33 mg/dl < SUA 5.11 mg/dl (n=69, 4.5%), and the highest quartile is SUA>5.11 mg/dl (n=70, 4.8%), respectively. SUA: serum uric acid. the predictors of MACE were ACS(OR:.09), multivessel disease(or: 3.684) and the SUA level(or: 1.7) in men, while multi-vessel disease(or.431) and the highest uric acid quartile(or.638) were the predictors of MACEs for women(table 4). According to the univariate analysis of the highest uric acid quartile for MACE, the highest uric acid quartile was associated with an increased risk of all MACEs (p=0.000), and CHF was the major contributor to the observed MACEs(p=0.004). For men, the highest uric acid quartile was not significantly associated with an increased risk of AMI, stroke, CABG, PCI, CHF, SCD and all MACEs. For women, the highest uric acid quartile was significantly associated with an increased risk of CHF(OR: 4.741, p=0.003) and all MACEs(OR:.748, p=0.005)(table 5). Discussion The main findings of this study were: 1) the incidence
4 Dae-Woo Hyun, et al: Uric Acid and the Prognosis for Female Patients with Coronary Artery Disease 199 Table. Prevalence of adverse cardiovascular events in the men and women according to the serum uric acid Variables All patients (n=660) Men (n=378) Women (n=8) p AMI 05 (0.8%) 03 (0.8%) 0 (0.7%) 0.90 Stroke 1 (1.8%) 07 (1.9%) 05 (1.8%) CABG 03 (0.5%) 0 (0.5%) 01 (0.4%) 0.74 PCI 1 (3.%) 11 (.9%) 10 (3.5%) CHF 30 (4.5%) 15 (4.0%) 15 (5.3%) SCD 03 (0.5%) 03 (0.8%) 00 (0.0%) AMI: acute myocardial infarction, CABG: coronary artery bypass surgery, PCI: percutaneous coronary intervention, CHF: congestive heart failure, SCD: sudden cardiac death, MACE: major adverse cardiovascular events Table 3. Hazard ratios of the clinical variables for major adverse cardiovascular events in the men and women by univariate Cox regression analysis Univariate predictors of MACE in men Univariate predictors of MACE in women Variables (n=660) OR (95% CI) p OR (95% CI) p Age ( ) ( ) BMI ( ) ( ) ACS.898 ( ) ( ) 0.08 Multi-vessel disease ( ) ( ) Risk factors Smoking ( ) ( ) Hypertension ( ) ( ) Diabetes ( ) ( ) Dyslipidemia ( ) ( ) Blood test Total cholesterol ( ) ( ) Triglycerides ( ) ( ) HDL cholesterol ( ) ( ) LDL cholesterol ( ) ( ) 0.86 Creatinine ( ) ( ) 0.11 Uric acid 1.73 ( ) ( ) Uric acid, highest quartile ( ) ( ) OR: odds ratio, CI: confidence interval, BMI: body mass index, ACS: acute coronary syndrome, HDL: high density lipoprotein, LDL: low density lipoprotein Table 4. Multivariate predictors of MACEs in men and women by Cox regression analysis Multivariate Cox regression of Variables MACE in men OR (95% CI) p ACS (%).09 ( ) Multi-vessel disease (%) ( ) Uric acid 1.7 ( ) Variables Multivariate Cox regression of MACE in women OR (95% CI) p ACS (%) ( ) Multi-vessel disease (%).431 ( ) 0.00 Uric acid, highest quartile.638 ( ) OR: odds ratio, CI: confidence interval, ACS: acute coronary syndrome of MACEs was associated with the SUA levels in men, whereas this was associated with the highest uric acid quartile in women. ) The highest uric acid quartile was associated with MACEs in women, mainly due to CHF, but it was not associated with MACEs in men. Recent studies have revealed the role of SUA as a predictor of mortality for patients with CAD, as well as association between SUA and other cardiovascular diseases or CAD. 5)6)11)1) However, the Framingham heart study failed to disclose the causal role of SUA in the development of CAD, death from cardiovascular disease or death from all causes. 8) Instead, uric acid has quite consistently been shown to be related with insulin resistance, endothelial dysfunction and the cardiovascular risk factors. )3)9)11) These findings represent that the SUA s role for the mortality of patients with CAD is possibly caused by the uric acid-related disorders. 5)6) The significant role of both the SUA and uric acid quartiles in MACEs of this study was mainly caused by the development of CHF in this study population, although each of these factors also showed a significant, but weak association with the development of AMI or PCI, respectively. An increased SUA level reflects the increased xanthine oxidase activity, which produces more free oxygen radicals. 1)14) This increased oxidative
5 00 Korean Circulation J 007;37: Table 5. Odds ratios of the highest uric acid quartile for major adverse cardiovascular events in the men and women by univariate Cox regression analysis MACE All patients Men Women OR (95% CI) p OR (95% CI) p OR (95% CI) p AMI ( ) ( ) ( ) Stroke ( ) ( ) ( ) CABG ( ) ( ) ( ) PCI.316 ( ) ( ) ( ) CHF.840 ( ) ( ) ( ) SCD ( ) ( ) 0.71 Total.887 ( ) ( ) ( ) OR: odds ratio, CI: confidence interval, MACE: major adverse cardiovascular events, AMI: acute myocardial infarction, CABG: coronary artery bypass graft, PCI: percutaneous coronary intervention, CHF: congestive heart failure, SCD: sudden cardiac death stress can induce endothelial dysfunction of the small myocardial vessels, and then myocardial dysfunction. 4) In addition, oxidative stress-induced nitric oxide breakdown decreases the Frank-Starling response in the heart. 14) which is one of the mechanism of decreased heart function by uric acid. SUA may increase in the failing circulation because of increased generation, decreased excretion or a combination of the factors. Further, high SUA levels are a strong independent marker of an impaired prognosis for patients with CHF. 1)7) SUA probably does not have a causal role in developing a poor prognosis. There have been no clinical trials that have specifically examined whether persons with hyperuricemia who are randomized to SUA-lowing therapy, either with allopurinol or a uricosuric agent, have a decreased risk of CAD events. The predictive role of uric acid for the development of heart failure in patients with CAD was also evident in a recent study performed on patients with AMI, 6) although there was a difference for uric acid with regard to mortality. The exact mechanism of uric acid on the development of CAD is not fully understood. Its association with insulin resistance, endothelial dysfunction and increased oxidative stress are possible mechanisms. )3)9)11)15)16) SUA levels rise steadily with age, with the levels in men beginning to rise during puberty. The SUA levels in women remain lower until menopause, possibly due to the effect of estrogen. 17) Although it is unclear how estrogen may lower the SUA levels, it has been observed that the SUA levels increase after menopause and that estrogen may increase the renal clearance of SUA. Several previous studies also have suggested that SUA may be a stronger predictor of CAD in women than for men. 18)19) Moriarity et al 9) reported that SUA was directly associated with the incidence of CAD in women and it was not significantly associated with the incidence of CAD in men. The incidence rate of CAD in women was increased primarily in the highest quartile of uric acid with there being little difference in the CAD incidence in the lower three quartiles. The relative risk in women was elevated only for the highest quartile, possibly suggesting a threshold of effect. Estrogen status is a marker of the prognosis for women with suspected CAD, 0) and SUA in women patients with CAD is also a predictor of cardiovascular events. Although the direct relationship between estrogen and SUA is not fully understood, estrogen may have an important role for the gender difference in the effects of SUA on future adverse cardiovascular events in the patients with CAD. It has been shown that hyperuricemia in the general population is associated with all-cause mortality. Therefore, assessing the SUA may be of good general value for both maintaining health and during illness, but the direct effect of uric acid has not yet been assessed in detail. Conclusion In summary, for the male patients with CAD, the serum uric acid levels are a predictor of cardiovascular events, and the highest uric acid quartile is a predictor of cardiovascular events in women. REFERENCES 1) Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 003;107: ) Mercuro G, Vitale C, Cerquetani E, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 004;94: ) Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;35: ) Cicoira M, Zanolla L, Rossi A, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J 00;143: ) Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 00; 89:1-7. 6) Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction. Am J Cardiol 005;96: ) Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival
6 Dae-Woo Hyun, et al: Uric Acid and the Prognosis for Female Patients with Coronary Artery Disease 01 in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 003;107: ) Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death. Ann Intern Med 1999;131: ) Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease. Ann Epidemiol 000;10: ) Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery diseae. Am J Cardiol 001; 87: ) Rich MW. Uric acid: is it a risk factor for cardiovascular disease? Am J Cardiol 000;85: ) Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34: ) McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;31: ) Prendergast BD, Sagach VF, Shah AM. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 1997;96: ) Lee JS, Park HG, Lee YM, Lee YW, Kim SW, Song CS. Observation of the serum uric acid in essential hypertension. Korean Circ J 1987;17: ) Yoo TW, Sung KC, Kim YC, et al. The relation of the hypertension, insulin resistance, and metabolic syndrome in the serum uric acid level. Korean Circ J 004;34: ) Nicholls A, Snaith ML, Scot JT. Effect of oestrogen theraphy on plasma and urinary levels of uric acid. Br Med J 1973;1: ) Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. Am J Epidemiol 1995;141: ) Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J. Hyperuricemia and risk of cardiovascular disease and overall death: a 1-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988;4: ) Morise AP. Assessment of estrogen status as a marker of prognosis in women with symptome of suspected coronary artery disease presenting for stress testing. Am J Cardiol 006;97:
Cover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationIncidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction
Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Sungmin Lim, Yoon Seok Koh, Hee Yeol Kim, Ik Jun Choi, Eun Ho Choo, Jin Jin Kim, Mineok
More informationInternational Journal of Pharma and Bio Sciences STUDY OF SERUM URIC ACID LEVELS IN ACUTE MYOCARDIAL INFARCTION ABSTRACT
Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 STUDY OF SERUM URIC ACID LEVELS IN ACUTE MYOCARDIAL INFARCTION DR. ABHISHEK DAS*, DR. DHANDAPANI E., DR. ARUN
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationClinical Value of Serum Uric Acid in Patients with Suspected Coronary Artery Disease
ORIGINAL ARTICLE DOI: 10.3904/kjim.2010.25.1.21 Clinical Value of Serum Uric Acid in Patients with Suspected Coronary Artery Disease Hong Euy Lim, Seong Hwan Kim, Eung Ju Kim, Jin Won Kim, Seung Woon Rha,
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationImpact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary
More informationPrevalence and Significance of Carotid Plaques in Patients With Coronary Atherosclerosis
ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.8.317 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Prevalence and Significance of Carotid Plaques in Patients
More informationAsian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017
Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute
More informationImpact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,
More informationThe MAIN-COMPARE Registry
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationTrial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial)
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial) Seung-Jung Park, MD, PhD On behalf of the BEST investigators Professor of Medicine, University of Ulsan College of
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationThe prognostic role of serum uric acid level in patients with acute ST elevation myocardial infarction
The prognostic role of serum uric acid level in patients with acute ST elevation myocardial infarction Bita Omidvar a, Fazlolah Ayatollahi a, Mohammad Alasti b, a Department of Internal Medicine, Golestan
More informationLow ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients
Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients N. Peltz-Sinvani, MD 1,4,R.Klempfner,MD 2,4, E. Ramaty, MD 1,4,B.A.Sela,PhD 3,4,I.Goldenberg,MD
More informationSmall dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study
Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationLong-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease
Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationKorea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea
Left Main Disease versus Non Left Main Disease in Acute Myocardial Infarction Patients in Real world Clinical Practice : Lessons from Korea Acute Myocardial Infarction Registry (KAMIR) Seung-Woon Rha*,
More informationDifferences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea
REVIEW DOI 10.4070 / kcj.2009.39.8.297 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Differences in Clinical Outcomes Between Patients With ST-Elevation
More informationSUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index
SUPPLEMENTAL MATERIAL Supplemental Methods Duke CAD Index The Duke CAD index, originally developed by David F. Kong, is an angiographic score that hierarchically assigns prognostic weights (0-100) based
More informationDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan
Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationWhat is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?
What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,
More informationThe Prognostic Significance of Carotid Intima-Media Thickness in Patients Who Underwent Percutaneous Coronary Intervention
Original ORIGINAL Article ARTICLE Korean Circulation J 2007;37:103-107 ISSN 1738-5520 c 2007, The Korean Society of Circulation The Prognostic Significance of Carotid Intima-Media Thickness in Patients
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationUric acid in Chronic Heart Failure; Correlation with Prognostic Markers
Ibnosina J Med BS 143 ARTICLE Uric acid in Chronic Heart Failure; Correlation with Prognostic Markers Fathia Ehmouda 1, Hamid Elbrasai 2, Ali M Elneihoum 1 1 Department of Medicine, 7 th October University
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationUric Acid Is Not An Independent Predictor of Cardiovascular Death in Patients with Angiographically Proven Coronary Artery Disease
Original Article 605 Uric Acid Is Not An Independent Predictor of Cardiovascular Death in Patients with Angiographically Proven Coronary Artery Disease Tzu-Hsien Tsai, MD; Yung-Lung Chen, MD; Shyh-Ming
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More information1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.
Midterm Clinical Outcomes of Insulin Requiring Diabetes Mellitus versus Non-insulin Dependent Diabetes Mellitus in Acute Myocardial Infarction Patients in Drug Eluting Stent Era : Insight from Korea Acute
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationMedicine OBSERVATIONAL STUDY
Medicine OBSERVATIONAL STUDY It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent Ju-Youn Kim,
More information10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice
10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationDECLARATION OF CONFLICT OF INTEREST. Nothing to disclose
DECLARATION OF CONFLICT OF INTEREST Nothing to disclose Four-Year Clinical Outcomes of the OLIVUS (Impact of OLmesartan on progression of coronary atherosclerosis; evaluation by IntraVascular UltraSound
More informationPCI vs. CABG From BARI to Syntax, Is The Game Over?
PCI vs. CABG From BARI to Syntax, Is The Game Over? Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea PCI vs CABG Multi-Vessel Disease
More informationSerum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease
Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationImpact of Lesion Length on Chronic Total Occlusion Intervention Outcomes
Impact of Lesion Length on Chronic Total Occlusion Intervention Outcomes Seung-Woon Rha, Amro Elnagar, Byoung Geol Choi, Sung Il Im, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim,
More informationCoronary Artery Stenosis. Insight from MAIN-COMPARE Study
PCI for Unprotected Left Main Coronary Artery Stenosis Insight from MAIN-COMPARE Study Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Asan Medical Center Current Practice
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationNew Generation Drug- Eluting Stent in Korea
New Generation Drug- Eluting Stent in Korea Young-Hak Kim, MD, PhD Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose To briefly introduce the
More informationRationale for Percutaneous Revascularization ESC 2011
Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following
More informationDiabetic Patients: Current Evidence of Revascularization
Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction
More informationNew insights in stent thrombosis: Platelet function monitoring. Franz-Josef Neumann Herz-Zentrum Bad Krozingen
New insights in stent thrombosis: Platelet function monitoring Franz-Josef Neumann Herz-Zentrum Bad Krozingen New insights in stent thrombosis: Platelet function monitoring Variability of residual platelet
More informationIntroduction. Subjects and Methods
ORIGINAL ARTICLE Korean Circ J 2007;37:538-542 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2007 The Korean Society of Cardiology Association of a Corrected QT Interval with the Carotid Intima-Media
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationFFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators
FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of
More informationBenefit of Performing PCI Based on FFR
Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided
More informationHeart Disease in Women. Charlotte A. Lee, M.D., DBIM, FLMI
Heart Disease in Women Charlotte A. Lee, M.D., DBIM, FLMI Heart Disease in Women Congenital Heart Disease Valvular Heart Disease Arrhythmias Cardiomyopathy Hypertension Coronary Artery Disease Coronary
More informationDevelopment of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery
Perry et al. Diagnostic and Prognostic Research (2019) 3:3 https://doi.org/10.1186/s41512-019-0048-7 Diagnostic and Prognostic Research RESEARCH Open Access Development of a risk score to identify patients
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationCan Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!
Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationJournal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32.
Journal of the American College of Cardiology Vol. 50, No. 11, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.05.035
More informationCARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial)
CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) William B. White, MD for the CARES Investigators Calhoun Cardiology Center University
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More informationResearch Article. Open Access
Journal of Geriatric Cardiology (2015) 12: 208 217 2015 JGC All rights reserved; www.jgc301.com Research Article Open Access Comparison of clinical outcomes between culprit vessel only and multivessel
More informationThis event does not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit
Welcome to this program sponsored by AstraZeneca The educator, who is presenting on behalf of AstraZeneca, is here to provide educational information pertinent to understanding the risk of a recurrent
More informationJun-Won Lee, Sang Wook Park, Jung-Woo Son, Young Jin Youn, Min-Soo Ahn, Sung Gyun Ahn, Jang-Young Kim, Byung-Soo Yoo, Junghan Yoon, Seung-Hwan Lee
The procedural success and complication rate of the left distal radial approach for coronary angiography and percutaneous coronary intervention. Prospective observational study (LeDRA) Jun-Won Lee, Sang
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationHow to detect early atherosclerosis ; focusing on techniques
How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial
More informationInfluence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the
More informationClinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at
More informationPeriprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol
More informationTCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI
Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi
More informationDiabetes and Occult Coronary Artery Disease
Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York
More informationEchocardiography analysis in renal transplant recipients
Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical
More informationDECISION-CTO. Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion. Seung-Jung Park, MD., PhD.
DECISION-CTO Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion Seung-Jung Park, MD., PhD. Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationRita Calé, Miguel Mendes, António Ferreira, João Brito, Pedro Sousa, Pedro Carmo, Francisco Costa, Pedro Adragão, João Calqueiro, José Aniceto Silva.
Peak Circulatory Power : a new parameter of cardiopulmonary exercise testing to predict arrhythmic events in patients with implantable cardioverter defibrillator for primary prevention Rita Calé, Miguel
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationClinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm
Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Department of Cardiology Keiji Inoue Akira Ueoka, Naoki Maruyama, Yoshiaki Shimoda, Eigo Kishita,
More informationThe Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
ORIGINAL ARTICLE DOI 10.4070 / kcj.2010.40.1.10 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2010 The Korean Society of Cardiology Open Access The Effect of Cilostazol on Stent Thrombosis
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationDiabetes, Insulin Resistance and Atherosclerosis Surrogates in Patients With Coronary Atherosclerosis
ORIGINAL ARTICLE DOI 10.4070 / kcj.2010.40.2.62 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2010 The Korean Society of Cardiology Open Access Diabetes, Insulin Resistance and Atherosclerosis
More informationSeung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Controversies in Acute Myocardial Infarction - Is Early Statin Therapy is Beneficial in all Patients?- : Insights from Korea Acute Myocardial Infarction Registry (KAMIR) Seung-Woon Rha, MD, PhD FACC, FAHA,
More informationExperience of Korea Acute Myocardial Infarction Registry (KAMIR)
Japan-Korea Joint AMI Symposium Korean Society of Myocardial Infarction Apr 18-19 2014 Experience of Korea Acute Myocardial Infarction Registry (KAMIR) Myung Ho Jeong, MD, PhD, FACC, FAHA, FESC, FSCAI,
More informationSerum Uric Acid and Cardiovascular Mortality
ORIGINAL CONTRIBUTION Acid and Cardiovascular Mortality The NHANES I Epidemiologic Follow-up Study, 1971-199 Jing Fang, MD Michael H. Alderman, MD Context Although many epidemiological studies have suggested
More information